tiprankstipranks
Ping An Healthcare and Technology Company Limited (DE:1XZ)
FRANKFURT:1XZ
Germany Market
1XZ
Ping An Healthcare and Technology Company
RESEARCH TOOLSreports

Ping An Healthcare and Technology Company (1XZ) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

1XZ Analyst Ratings

Moderate Buy
2Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Ping
An Healthcare and Technology Company
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1XZ Stock 12 Month Forecast

Average Price Target

€1.61
▲(89.37% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Ping An Healthcare and Technology Company in the last 3 months. The average price target is €1.61 with a high forecast of €1.97 and a low forecast of €1.25. The average price target represents a 89.37% change from the last price of €0.85.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","1":"€1","2":"€2","3":"€3","-1":"-€1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.970982,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€1.97</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.6096352999999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€1.61</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.2482886,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€1.25</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0,1,2,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.848,0.9343832307692308,1.0207664615384615,1.1071496923076922,1.1935329230769232,1.2799161538461539,1.3662993846153846,1.4526826153846155,1.539065846153846,1.625449076923077,1.7118323076923077,1.7982155384615384,1.8845987692307693,{"y":1.970982,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.848,0.9065873307692307,0.9651746615384615,1.0237619923076924,1.082349323076923,1.1409366538461538,1.1995239846153845,1.2581113153846153,1.3166986461538461,1.375285976923077,1.4338733076923076,1.4924606384615382,1.551047969230769,{"y":1.6096352999999999,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.848,0.8787914307692307,0.9095828615384615,0.9403742923076923,0.9711657230769231,1.0019571538461538,1.0327485846153845,1.0635400153846153,1.094331446153846,1.125122876923077,1.1559143076923077,1.1867057384615385,1.2174971692307692,{"y":1.2482886,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.288,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.32,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.976,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.509,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.618,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.542,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.507,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.314,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.318,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.164,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.986,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.77,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.848,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€1.97Average Price Target€1.61Lowest Price Target€1.25
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Huatai Securities Analyst forecast on DE:1XZ
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
€1.25
Buy
46.86%
Upside
Reiterated
08/20/26
Huatai Securities Sticks to Their Buy Rating for Ping An Healthcare and Technology Company (PANHF)
Citi Analyst forecast on DE:1XZ
Unknown Analyst
Citi
Not Ranked
Citi
€1.97
Buy
131.88%
Upside
Reiterated
07/21/26
Citi Sticks to Its Buy Rating for Ping An Healthcare and Technology Company (PANHF)
CICC Analyst forecast on DE:1XZ
Unknown Analyst
CICC
Not Ranked
CICC
€1.55
Buy
82.93%
Upside
Reiterated
05/15/26
CICC Reaffirms Their Buy Rating on Ping An Healthcare and Technology Company (PANHF)
UOB Kay Hian Analyst forecast on DE:1XZ
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
€1.92→€1.59
Buy
86.79%
Upside
Reiterated
04/24/26
Ping An Healthcare and Technology Company (PANHF) Receives a Buy from UOB Kay Hian
Morgan Stanley Analyst forecast on DE:1XZ
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
€1.84
Hold
116.42%
Upside
Reiterated
04/23/26
Ping An Healthcare and Technology Company (PANHF) Receives a Hold from Morgan Stanley
GF Securities Analyst forecast on DE:1XZ
Unknown Analyst
GF Securities
Not Ranked
GF Securities
€2.15→€1.8
Buy
112.04%
Upside
Reiterated
04/07/26
GF Securities Remains a Buy on Ping An Healthcare and Technology Company (PANHF)
China Renaissance Analyst forecast on DE:1XZ
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
€2.61
Buy
207.63%
Upside
Reiterated
04/04/26
China Renaissance Sticks to Its Buy Rating for Ping An Healthcare and Technology Company (PANHF)
CLSA Analyst forecast on DE:1XZ
Unknown Analyst
CLSA
Not Ranked
CLSA
€2.08
Buy
144.76%
Upside
Reiterated
03/26/26
CLSA Keeps Their Buy Rating on Ping An Healthcare and Technology Company (PANHF)
UBS Analyst forecast on DE:1XZ
Unknown Analyst
UBS
Not Ranked
UBS
€1.59
Hold
86.79%
Upside
Reiterated
03/25/26
UBS Remains a Hold on Ping An Healthcare and Technology Company (PANHF)
Jefferies Analyst forecast on DE:1XZ
Cui Cui
Jefferies
Jefferies
€1.36
Hold
59.74%
Upside
Reiterated
03/25/26
Jefferies Reaffirms Their Hold Rating on Ping An Healthcare and Technology Company (PANHF)
Citic Securities Analyst forecast on DE:1XZ
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
€2.3
Buy
170.53%
Upside
Reiterated
11/25/25
SPDB Analyst forecast on DE:1XZ
Unknown Analyst
SPDB
Not Ranked
SPDB
€1.53
Sell
80.35%
Upside
Reiterated
10/28/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Huatai Securities Analyst forecast on DE:1XZ
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
€1.25
Buy
46.86%
Upside
Reiterated
08/20/26
Huatai Securities Sticks to Their Buy Rating for Ping An Healthcare and Technology Company (PANHF)
Citi Analyst forecast on DE:1XZ
Unknown Analyst
Citi
Not Ranked
Citi
€1.97
Buy
131.88%
Upside
Reiterated
07/21/26
Citi Sticks to Its Buy Rating for Ping An Healthcare and Technology Company (PANHF)
CICC Analyst forecast on DE:1XZ
Unknown Analyst
CICC
Not Ranked
CICC
€1.55
Buy
82.93%
Upside
Reiterated
05/15/26
CICC Reaffirms Their Buy Rating on Ping An Healthcare and Technology Company (PANHF)
UOB Kay Hian Analyst forecast on DE:1XZ
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
€1.92→€1.59
Buy
86.79%
Upside
Reiterated
04/24/26
Ping An Healthcare and Technology Company (PANHF) Receives a Buy from UOB Kay Hian
Morgan Stanley Analyst forecast on DE:1XZ
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
€1.84
Hold
116.42%
Upside
Reiterated
04/23/26
Ping An Healthcare and Technology Company (PANHF) Receives a Hold from Morgan Stanley
GF Securities Analyst forecast on DE:1XZ
Unknown Analyst
GF Securities
Not Ranked
GF Securities
€2.15→€1.8
Buy
112.04%
Upside
Reiterated
04/07/26
GF Securities Remains a Buy on Ping An Healthcare and Technology Company (PANHF)
China Renaissance Analyst forecast on DE:1XZ
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
€2.61
Buy
207.63%
Upside
Reiterated
04/04/26
China Renaissance Sticks to Its Buy Rating for Ping An Healthcare and Technology Company (PANHF)
CLSA Analyst forecast on DE:1XZ
Unknown Analyst
CLSA
Not Ranked
CLSA
€2.08
Buy
144.76%
Upside
Reiterated
03/26/26
CLSA Keeps Their Buy Rating on Ping An Healthcare and Technology Company (PANHF)
UBS Analyst forecast on DE:1XZ
Unknown Analyst
UBS
Not Ranked
UBS
€1.59
Hold
86.79%
Upside
Reiterated
03/25/26
UBS Remains a Hold on Ping An Healthcare and Technology Company (PANHF)
Jefferies Analyst forecast on DE:1XZ
Cui Cui
Jefferies
Jefferies
€1.36
Hold
59.74%
Upside
Reiterated
03/25/26
Jefferies Reaffirms Their Hold Rating on Ping An Healthcare and Technology Company (PANHF)
Citic Securities Analyst forecast on DE:1XZ
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
€2.3
Buy
170.53%
Upside
Reiterated
11/25/25
SPDB Analyst forecast on DE:1XZ
Unknown Analyst
SPDB
Not Ranked
SPDB
€1.53
Sell
80.35%
Upside
Reiterated
10/28/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ping An Healthcare and Technology Company

3 Months
PerPlexity Medical - Healthcare Information ServicesTipRanks - PerPlexity
Success Rate
0/1 ratings generated profit
0%
Average Return
0.00%
Copying PerPlexity Medical - Healthcare Information Services's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
1 Year
PerPlexity Medical - Healthcare Information ServicesTipRanks - PerPlexity
Success Rate
0/1 ratings generated profit
0%
Average Return
0.00%
Copying PerPlexity Medical - Healthcare Information Services's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
PerPlexity Medical - Healthcare Information ServicesTipRanks - PerPlexity
Success Rate
0/1 ratings generated profit
0%
Average Return
0.00%
Copying PerPlexity Medical - Healthcare Information Services's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1XZ Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
2
2
1
1
2
Buy
7
6
3
1
0
Hold
3
3
1
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
11
5
2
2
In the current month, 1XZ has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 1XZ average Analyst price target in the past 3 months is 1.61.
Each month's total comprises the sum of three months' worth of ratings.

1XZ Financial Forecast

1XZ Earnings Forecast

The previous quarter’s earnings for 1XZ were €0.01.
The previous quarter’s earnings for 1XZ were €0.01.

1XZ Sales Forecast

The previous quarter’s earnings for 1XZ were €309.18M.
The previous quarter’s earnings for 1XZ were €309.18M.

1XZ Stock Forecast FAQ

What is DE:1XZ’s average 12-month price target, according to analysts?
Based on analyst ratings, Ping An Healthcare and Technology Company Limited’s 12-month average price target is 1.61.
    What is DE:1XZ’s upside potential, based on the analysts’ average price target?
    Ping An Healthcare and Technology Company Limited has 89.37% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Ping An Healthcare and Technology Company Limited a Buy, Sell or Hold?
          Ping An Healthcare and Technology Company Limited has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Ping An Healthcare and Technology Company Limited’s share price target?
            The average share price target for Ping An Healthcare and Technology Company Limited is 1.61. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €1.97 ,and the lowest forecast is €1.25. The average share price target represents 89.37% Increase from the current price of €0.85.
              What do analysts say about Ping An Healthcare and Technology Company Limited?
              Ping An Healthcare and Technology Company Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
                How can I buy shares of Ping An Healthcare and Technology Company Limited?
                To buy shares of DE:1XZ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.